ArticleInflammopharmacology2025
Evaluating diclofenac's risks in COVID-19: strategies for mitigating adverse outcomes.
Chia Siang Kow et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleInflammopharmacology2025
Chia Siang Kow et al.PubMed ↗Publisher ↗
No numbers read from the abstract.